BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Interesting work, engaging team, and happy to be a part of it
Quelles sont les meilleures choses à propos de votre équipe?
Collaborative, insightful, supportive and genuinely great people
Qu’est-ce qui vous rend le plus heureux au travail?
Co-workers and being involved in cutting edge science
Quelle est la meilleure partie de votre programme de rémunération?
Good salary, great benefits, and a decent bonus.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Forward thinking and quite transparent
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Employee support, engagement, celebrations and trying to connect and bring us together, despite the pandemic. Overall, a great workplace
Other Employee Reviews for BlueRock Therapeutics
×